DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,124,862 | -20.3% | 402,898 | -3.2% | 0.00% | -33.3% |
Q2 2023 | $6,431,927 | 0.0% | 416,306 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $6,431,927 | +991.6% | 416,306 | +1058.0% | 0.00% | – |
Q4 2022 | $589,236 | -99.9% | 35,951 | -31.7% | 0.00% | -100.0% |
Q3 2022 | $973,786,000 | +46.6% | 52,637 | +4.2% | 0.00% | – |
Q2 2022 | $664,220,000 | +60.4% | 50,511 | +13.1% | 0.00% | – |
Q1 2022 | $414,129,000 | -5.1% | 44,674 | 0.0% | 0.00% | – |
Q4 2021 | $436,465,000 | -96.4% | 44,674 | -87.5% | 0.00% | -100.0% |
Q3 2021 | $12,152,028,000 | -15.5% | 357,623 | -9.0% | 0.01% | -16.7% |
Q2 2021 | $14,386,925,000 | +12.3% | 392,978 | +37.5% | 0.01% | 0.0% |
Q1 2021 | $12,815,318,000 | -42.2% | 285,801 | -26.4% | 0.01% | -40.0% |
Q4 2020 | $22,155,201,000 | +52.4% | 388,211 | +37.0% | 0.01% | +25.0% |
Q3 2020 | $14,537,857,000 | -10.1% | 283,389 | +4.7% | 0.01% | -20.0% |
Q2 2020 | $16,166,980,000 | +38.6% | 270,713 | -4.5% | 0.01% | +25.0% |
Q1 2020 | $11,667,661,000 | -39.9% | 283,402 | -9.1% | 0.01% | -33.3% |
Q4 2019 | $19,402,946,000 | +151.8% | 311,744 | +37.3% | 0.01% | +140.0% |
Q3 2019 | $7,704,346,000 | – | 226,999 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |